Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
[MOLECULAR-BIOLOGICAL MARKERS OF HEPATITIS B IN PATIENTS WITH LIVER FIBROSIS/CIRRHOSIS IN UZBEKISTAN]
Hepatitis B virus (HBV) genotype D, particularly subtype D1, is highly prevalent (82%) in Uzbekistan among patients with liver disease. This finding is crucial for developing effective HBV prevention and treatment strategies in Central Asia.
Area of Science:
- Hepatology
- Virology
- Genetics
Background:
- Hepatitis B virus (HBV) infection remains a significant global health concern, particularly in Central Asia.
- Understanding HBV genotypes and subtypes is crucial for effective disease management and prevention strategies.
Purpose of the Study:
- To evaluate the prevalence of hepatitis B virus genetic variants in Uzbekistan.
- To analyze HBV genotypes and subtypes in patients with varying degrees of liver fibrosis and cirrhosis.
Main Methods:
- Direct sequencing of the Pre-S1/Pre-S2/S HBV DNA region was used for genotyping.
- Phylogenetic analysis was performed on samples from 39 patients with liver fibrosis and cirrhosis.
Main Results:
- Hepatitis B virus was detected in 82% of the studied samples.
- Only genotype D was identified, with subtype D1 predominating (84.38%), followed by D3 (12.5%) and D2 (3.12%).
Conclusions:
- The study highlights the dominance of HBV genotype D, specifically subtype D1, in the Uzbek population.
- Large-scale HBV sequencing in Central Asia is essential for understanding transmission routes and evolutionary history, aiding in prophylaxis and therapy development.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
What is Conservation Biology?
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Molecular Models

